Citadel Advisors
TWST icon

Citadel Advisors’s Twist Bioscience TWST Stock Holding History

Citadel Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65M Sell
25,800
-29,600
-53% -$1.93M ﹤0.01% 5932
2026
Q1 		$2.63M Buy
55,400
+23,200
+72% +$1.04M ﹤0.01% 5517
2025
Q4 		$1.02M Sell
32,200
-6,300
-16% -$197K ﹤0.01% 7350
2025
Q3 		$1.08M Buy
38,500
+10,700
+38% +$324K ﹤0.01% 7366
2025
Q2 		$1.02M Buy
27,800
+5,900
+27% +$204K ﹤0.01% 7039
2025
Q1 		$860K Buy
21,900
+12,800
+141% +$577K ﹤0.01% 7300
2024
Q4 		$423K Buy
9,100
+4,300
+90% +$194K ﹤0.01% 8931
2024
Q3 		$217K Sell
4,800
-6,500
-58% -$309K ﹤0.01% 9981
2024
Q2 		$557K Sell
11,300
-7,100
-39% -$290K ﹤0.01% 7839
2024
Q1 		$631K Sell
18,400
-67,700
-79% -$2.44M ﹤0.01% 7874
2023
Q4 		$3.17M Buy
86,100
+44,200
+105% +$1.02M ﹤0.01% 4542
2023
Q3 		$849K Sell
41,900
-36,900
-47% -$811K ﹤0.01% 6914
2023
Q2 		$1.61M Buy
78,800
+45,500
+137% +$682K ﹤0.01% 5551
2023
Q1 		$502K Buy
33,300
+20,800
+166% +$459K ﹤0.01% 8299
2022
Q4 		$298K Buy
12,500
+6,100
+95% +$177K ﹤0.01% 9339
2022
Q3 		$226K Sell
6,400
-7,300
-53% -$310K ﹤0.01% 10160
2022
Q2 		$479K Sell
13,700
-10,000
-42% -$354K ﹤0.01% 8745
2022
Q1 		$1.17M Buy
23,700
+1,300
+6% +$72K ﹤0.01% 7350
2021
Q4 		$1.73M Buy
22,400
+2,800
+14% +$287K ﹤0.01% 6581
2021
Q3 		$2.1M Sell
19,600
-3,400
-15% -$389K ﹤0.01% 6239
2021
Q2 		$3.06M Sell
23,000
-16,100
-41% -$1.87M ﹤0.01% 5551
2021
Q1 		$4.84M Buy
39,100
+7,500
+24% +$1.14M ﹤0.01% 4321
2020
Q4 		$4.46M Buy
31,600
+22,100
+233% +$2.45M ﹤0.01% 3872
2020
Q3 		$722K Buy
9,500
+4,300
+83% +$268K ﹤0.01% 6629
2020
Q2 		$236K Buy
+5,200
New +$187K ﹤0.01% 8287

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Citadel Advisors's TWST Position: Q2 2026 in Review

Citadel Advisors reduced its Twist Bioscience (TWST) stake by 29% in Q2 2026, selling an estimated $23.3M and leaving 862,042 shares worth $88.7M. The position accounts for 0.01% of the portfolio, ranked #1064.

Citadel Advisors first reported a position in TWST in Q3 2019 and has held it in 27 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Citadel Advisors held 862,042 shares of Twist Bioscience worth $88.7M as of Q2 2026.
  • Citadel Advisors sold 358,358 Twist Bioscience shares in Q2 2026, an estimated $23.3M.
  • Twist Bioscience made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1064 holding.
  • Citadel Advisors first reported a position in Twist Bioscience in Q3 2019 and has held it in 27 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.